Nifedipine sustained release tablets and preparation process thereof
A technology for nifedipine and preparation process, which is applied in the directions of non-active ingredient medical preparations, medical preparations containing active ingredients, and pill delivery, etc. problem, to achieve the effect of slow dissolution rate, simple production process, and easy mass production
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0016] Example 1
[0017] The sustained-release nifedipine tablets of the present invention are prepared from the following raw materials and auxiliary materials in the following weight ratios:
[0018] Nifedipine 20%
[0019] Chitosan 14%
[0020] Dextrin 60%
[0021] Ethyl cellulose 4%
[0022] Sodium lauryl sulfate 1%
[0023] Magnesium stearate 1%
[0024] Among them, nifedipine is a raw material, chitosan is a slow release agent, dextrin is a filler, ethyl cellulose is a binder, sodium lauryl sulfate is a solubilizer, and magnesium stearate is a lubricant.
[0025] Preparation process: pulverize nifedipine and pass it through a 200-mesh stainless steel sieve; mix nifedipine, chitosan, sodium lauryl sulfate and dextrin by weight percentage; after the raw and auxiliary materials are evenly mixed, add ethyl Ethyl cellulose with a weight concentration of 8% made by adding 80% ethanol to the cellulose—a soft material made of 80% ethanol solution; the soft material is passed through a 20-me...
Example Embodiment
[0026] Example 2
[0027] The sustained-release nifedipine tablets of the present invention are prepared from the following raw materials and auxiliary materials in the following weight ratios:
[0028] Nifedipine 20%
[0029] Chitosan 17%
[0030] Dextrin 57%
[0031] Ethyl cellulose 4%
[0032] Sodium lauryl sulfate 1%
[0033] Magnesium stearate 1%
[0034] Among them, nifedipine is a raw material, chitosan is a slow release agent, dextrin is a filler, ethyl cellulose is a binder, sodium lauryl sulfate is a solubilizer, and magnesium stearate is a lubricant.
[0035] Preparation process: crush nifedipine and pass it through a 200-mesh stainless steel sieve; mix nifedipine, chitosan, sodium lauryl sulfate and dextrin by weight percentage; add ethyl cellulose after the raw and auxiliary materials are evenly mixed —80% ethanol solution to make soft materials; pass the soft materials through a 20-mesh stainless steel sieve to make wet granules; dry the wet granules at a temperature of 55℃~6...
Example Embodiment
[0036] Example 3
[0037] The sustained-release nifedipine tablets of the present invention are prepared from the following raw materials and auxiliary materials in the following weight ratios:
[0038] Nifedipine 20%
[0039] Chitosan 20%
[0040] Dextrin 54%
[0041] Ethyl cellulose 4%
[0042] Sodium lauryl sulfate 1%
[0043] Magnesium stearate 1%
[0044] Among them, nifedipine is a raw material, chitosan is a slow release agent, dextrin is a filler, ethyl cellulose is a binder, sodium lauryl sulfate is a solubilizer, and magnesium stearate is a lubricant.
[0045] Preparation process: crush nifedipine and pass it through a 200-mesh stainless steel sieve; mix nifedipine, chitosan, sodium lauryl sulfate and dextrin by weight percentage; add ethyl cellulose after the raw and auxiliary materials are evenly mixed —80% ethanol solution to make soft materials; pass the soft materials through a 20-mesh stainless steel sieve to make wet granules; dry the wet granules at a temperature of 55℃~6...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap